{"id": "1349722235104358403", "creation": 1610633832.0, "user_id": "1247376635004936192", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 0, "reply_count": 0, "like_count": 0, "quote_count": 0}}, "text": "Interim Results of a Phase 1\u20132a Trial of Ad26.COV2.S (J&amp;J) #COVID19 #Vaccine\n\nThe safety and immunogenicity profiles of Ad26.COV2.S support further development of this #CovidVaccine  candidate.\nhttps://t.co/0cG1r2NYqV https://t.co/ASRFAIjbOq", "first_save": 1634559108.199414, "hashtags": ["#COVID19", "#VACCINE", "#COVIDVACCINE"]}